BIOTECHNOLOGY

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

“MERCURIUS Total DRUG-seq represents a new frontier in transcriptome-scale compound [...]

By |2025-06-19T15:15:59+00:00June 19, 2025|3rd Party Medical Device Industry News|Comments Off on Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
Go to Top